Aptamimetics
Berlin, Germany· Est. 2016
Aptamimetics develops next generation biopharmaceuticals based on nucleic acids to address unmet medical needs.
Private Company
Total funding raised: $1.9M
About
Aptamimetics develops next generation biopharmaceuticals based on nucleic acids to address unmet medical needs.
AntibodiesDiagnostics
Funding History
2Total raised:$1.9M
Grant$750KJun 15, 2020
Seed$1.2MJun 15, 2019